Maniatis, T. (2024). From bacterial operons to gene therapy: 50 years of the journal Cell. Cell, 187(23), 6417–6420. https://doi.org/10.1016/j.cell.2024.10.037

George, S. A., Veludhandi, A., Xiang, Y., Liu, K., Stenger, E., Arnold, S. D., Mehta, A., Schirmer, D. A., Spencer, J. B., Guilcher, G. M. T., Bhatia, M., Abraham, A., Gomez-Lobo, V., Krishnamurti, L., & Meacham, L. R. (2024). Reproductive Health Assessment and Reports of Fertility Counseling in Pediatric and Adolescent Patients with Sickle Cell Disease After Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy, 30(9), 912.e1-912.e13. https://doi.org/10.1016/j.jtct.2024.06.029

Smaldone, A., Manwani, D., Aygun, B., Appiah‐Kubi, A., Smith‐Whitley, K., & Green, N. S. (2024). Assessing multilevel barriers to hydroxyurea adherence in youth with sickle cell disease using pharmacy‐based refill records. Pediatric Blood & Cancer, 71(9). Portico. https://doi.org/10.1002/pbc.31170

Arnold, S. D., Bakshi, N., Ross, D., Smith, C., Sinha, C., Veludhandi, A., Dutreuil, V., Bai, S., Meacham, L. R., Guilcher, G., Bhatia, M., Abraham, A., Kasow, K. A., Haight, A., El Rassi, F., Stenger, E., Lipscomb, J., & Krishnamurti, L. (2024). Long‐term quality of life after hematopoietic cell transplant for sickle cell disease in childhood: A STELLAR interim analysis. American Journal of Hematology, 99(10), 2037–2040. Portico. https://doi.org/10.1002/ajh.27436

Yee, M. E. M., Covington, M. L., Zerra, P. E., McCoy, J. W., Easley, K. A., Joiner, C. H., Bryksin, J., Francis, R. O., Lough, C. M., Patel, N., Kutlar, A., Josephson, C. D., Roback, J. D., Stowell, S. R., & Fasano, R. M. (2024). Survival of transfused red blood cells from a donor with alpha‐thalassemia trait in a recipient with sickle cell disease. Transfusion, 64(6), 1109–1115. Portico. https://doi.org/10.1111/trf.17857

Frangoul, H., Locatelli, F., Sharma, A., Bhatia, M., Mapara, M., Molinari, L., Wall, D., Liem, R. I., Telfer, P., Shah, A. J., Cavazzana, M., Corbacioglu, S., Rondelli, D., Meisel, R., Dedeken, L., Lobitz, S., de Montalembert, M., Steinberg, M. H., Walters, M. C., … Grupp, S. A. (2024). Exagamglogene Autotemcel for Severe Sickle Cell Disease. New England Journal of Medicine, 390(18), 1649–1662. https://doi.org/10.1056/nejmoa2309676

Aron, J. A., Healy, E. W., Robinson, J. R. M., & Blinderman, C. D. (2024). Effects of Medical Cannabis Certification on Hospital Use by Individuals with Sickle Cell Disease. Cannabis and Cannabinoid Research, 9(2), 629–634. https://doi.org/10.1089/can.2022.0136

Green, N. S., Manwani, D., Aygun, B., Appiah‐Kubi, A., Smith‐Whitley, K., Castillo, Y., Soriano, L., Jia, H., & Smaldone, A. M. (2024). Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment (HABIT) efficacy trial: Community health worker support may increase hydroxyurea adherence of youth with sickle cell disease. Pediatric Blood & Cancer, 71(4). Portico. https://doi.org/10.1002/pbc.30878

Mishkin, A. D., Prince, E. J., Leimbach, E. J., Mapara, M. Y., & Carroll, C. P. (2023). Psychiatric comorbidities in adults with sickle cell disease: A narrative review. British Journal of Haematology, 203(5), 747–759. Portico. https://doi.org/10.1111/bjh.18981

Green, N. S., Rosano, C., Bangirana, P., Opoka, R., Munube, D., Kasirye, P., Kawooya, M., Lubowa, S. K., Mupere, E., Conroy, A., Minja, F. J., Boehme, A. K., Kang, M. S., Honig, L. S., & Idro, R. (2023). Neurofilament light chain: A potential biomarker for cerebrovascular disease in children with sickle cell anaemia. British Journal of Haematology, 203(3), 460–467. Portico. https://doi.org/10.1111/bjh.19036

Kinoshita, H., Mandava, M., Jensen-Wachspress, M., Lang, H., Joy, E., Tanna, J., McCann, C. D., O’Brien, S., Burnett, S., Shibli, A., Hoq, F., Bhatia, M., Hanley, P. J., Dávila Saldaña, B., Mahadeo, K. M., Bollard, C. M., Keller, M. D., & Abraham, A. (2023). Outcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell disease. Blood Advances, 7(10), 2105–2116. https://doi.org/10.1182/bloodadvances.2022008219

De, A., Williams, S., Yao, Y., Jin, Z., Brittenham, G. M., Kattan, M., Lovinsky-Desir, S., & Lee, M. T. (2023). Acute chest syndrome, airway inflammation and lung function in sickle cell disease. PLOS ONE, 18(3), e0283349. https://doi.org/10.1371/journal.pone.0283349

Reeves, S. L., Peng, H. K., Wing, J. J., Cogan, L. W., Goel, A., Anders, D., Green, N. S., Lisabeth, L. D., & Dombkowski, K. J. (2023). Changes in Hydroxyurea Use Among Youths Enrolled in Medicaid With Sickle Cell Anemia After 2014 Revision of Clinical Guidelines. JAMA Network Open, 6(3), e234584. https://doi.org/10.1001/jamanetworkopen.2023.4584

Pecker, L. H., Oteng-Ntim, E., Nero, A., Lanzkron, S., Christianson, M. S., Woolford, T., Meacham, L. R., & Mishkin, A. D. (2023). Expecting more: the case for incorporating fertility services into comprehensive sickle cell disease care. The Lancet Haematology, 10(3), e225–e234. https://doi.org/10.1016/s2352-3026(22)00353-2

Stenger, E., Xiang, Y., Wetzel, M., Gillespie, S., Chellapandian, D., Shah, R., Arnold, S. D., Bhatia, M., Chaudhury, S., Eckrich, M. J., Kanter, J., Kasow, K. A., Krajewski, J., Nickel, R. S., Ngwube, A. I., Olson, T. S., Rangarajan, H. G., Wobma, H., Guilcher, G. M. T., … Abraham, A. (2023). Long-Term Organ Function After HCT for SCD: A Report From the Sickle Cell Transplant Advocacy and Research Alliance. Transplantation and Cellular Therapy, 29(1), 47.e1-47.e10. https://doi.org/10.1016/j.jtct.2022.10.012

Rizvi, M. B., Kessler, D. O., & Rabiner, J. E. (2022). Role of regional anesthesia in patients with acute sickle cell pain: A scoping review. Pediatric Blood & Cancer, 70(1). Portico. https://doi.org/10.1002/pbc.30063

Green, N. S., Zapfel, A., Nnodu, O. E., Franklin, P., Tubman, V. N., Chirande, L., Kiyaga, C., Chunda-Liyoka, C., Awuonda, B., Ohene-Frempong, K., Inusa, B. P. D., Ware, R. E., Odame, I., Ambrose, E. E., Dogara, L. G., Oron, A. P., Willett, C., Thompson, A. A., Berliner, N., … Novelli, E. M. (2022). The Consortium on Newborn Screening in Africa for sickle cell disease: study rationale and methodology. Blood Advances, 6(24), 6187–6197. https://doi.org/10.1182/bloodadvances.2022007698

Meacham, L. R., Pecker, L. H., Gee, B., & Mishkin, A. (2022). Incorporating gonadal health counseling into pediatric care of sickle cell patients. Hematology, 2022(1), 442–449. https://doi.org/10.1182/hematology.2022000382

Mishkin, A. D., Cheung, S. G., Hoffman, A., Leimbach, E. J., Dosovitz, S., & Mapara, M. (2022). High incidence of suicidal ideation in a series of patients with sickle cell disease after hematopoietic stem cell transplantation. Blood Advances, 6(19), 5542–5545. https://doi.org/10.1182/bloodadvances.2021006752

Tolu, S. S., & Van Doren, L. (2022). Acute and chronic pain management in patients with sickle cell disease in the modern era: a comprehensive review. Transfusion and Apheresis Science, 61(5), 103533. https://doi.org/10.1016/j.transci.2022.103533

Askew, M. A., Smaldone, A. M., Gold, M. A., Smith‐Whitley, K., Strouse, J. J., Jin, Z., & Green, N. S. (2022). Pediatric hematology providers’ contraceptive practices for female adolescents and young adults with sickle cell disease: A national survey. Pediatric Blood & Cancer, 69(10). Portico. https://doi.org/10.1002/pbc.29877

Waldron, E., & Tanhehco, Y. C. (2022). Under the hood: The molecular biology driving gene therapy for the treatment of sickle cell disease. Transfusion and Apheresis Science, 61(5), 103566. https://doi.org/10.1016/j.transci.2022.103566

Lee, M. T., & Ogu, U. O. (2022). Sickle cell disease in the new era: advances in drug treatment. Transfusion and Apheresis Science, 61(5), 103555. https://doi.org/10.1016/j.transci.2022.103555

Lewis, J., Greenway, S. C., Khan, F., Singh, G., Bhatia, M., & Guilcher, G. M. T. (2022). Assessment of donor cell engraftment after hematopoietic stem cell transplantation for sickle cell disease: A review of current and future methods. American Journal of Hematology, 97(10), 1359–1371. Portico. https://doi.org/10.1002/ajh.26599

Green, N. S., Manwani, D., Smith‐Whitley, K., Aygun, B., Appiah‐Kubi, A., & Smaldone, A. M. (2022). Mental health assessment of youth with sickle cell disease and their primary caregivers during the COVID‐19 pandemic. Pediatric Blood & Cancer, 69(9). Portico. https://doi.org/10.1002/pbc.29797

Moriconi, C., Dzieciatkowska, M., Roy, M., D’Alessandro, A., Roingeard, P., Lee, J. Y., Gibb, D. R., Tredicine, M., McGill, M. A., Qiu, A., La Carpia, F., Francis, R. O., Hod, E. A., Thomas, T., Picard, M., Akpan, I. J., Luckey, C. J., Zimring, J. C., Spitalnik, S. L., & Hudson, K. E. (2022). Retention of functional mitochondria in mature red blood cells from patients with sickle cell disease. British Journal of Haematology, 198(3), 574–586. Portico. https://doi.org/10.1111/bjh.18287

Kwarteng-Siaw, M., Benneh-Akwasi Kuma, A., & Green, N. S. (2021). Transition Preparation and Satisfaction of Care Among Adolescents and Young Adults With Sickle Cell Disease at the Ghana Institute of Clinical Genetics. Journal of Pediatric Hematology/Oncology, 44(3), e682–e688. https://doi.org/10.1097/mph.0000000000002316

Idro, R., Boehme, A. K., Kawooya, M., Lubowa, S. K., Munube, D., Bangirana, P., Opoka, R., Mupere, E., Lignelli, A., Kasirye, P., Green, N. S., & Minja, F. J. (2022). Brain Magnetic Resonance Imaging and Angiography in Children with Sickle Cell Anaemia in Uganda in a Cross-Sectional Sample. Journal of Stroke and Cerebrovascular Diseases, 31(4), 106343. https://doi.org/10.1016/j.jstrokecerebrovasdis.2022.106343

Yee, M. E., Francis, R. O., Luban, N. L. C., Easley, K. A., Lough, C. M., Roback, J. D., Josephson, C. D., & Fasano, R. M. (2022). Glucose‐6‐phosphate dehydrogenase deficiency is more prevalent in Duffy‐null red blood cell transfusion in sickle cell disease. Transfusion, 62(3), 551–555. Portico. https://doi.org/10.1111/trf.16806

Kanter, J., Walters, M. C., Krishnamurti, L., Mapara, M. Y., Kwiatkowski, J. L., Rifkin-Zenenberg, S., Aygun, B., Kasow, K. A., Pierciey, F. J., Bonner, M., Miller, A., Zhang, X., Lynch, J., Kim, D., Ribeil, J.-A., Asmal, M., Goyal, S., Thompson, A. A., & Tisdale, J. F. (2022). Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease. New England Journal of Medicine, 386(7), 617–628. https://doi.org/10.1056/nejmoa2117175